☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada
October 7, 2020
Merck Signs an Out-Licensing Agreement with Novartis for M6495 (Anti-ADAMTS5 Nanobody) for Osteoarthritis
October 7, 2020
BioNTech and Pfizer Initiates Rolling Submission to EMA for SARS-CoV-2 Vaccine Candidate- BNT162b2
October 7, 2020
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11 (biosimilar- ranibizumab)
October 7, 2020
GSK Signs an Agreement with Vir Biotechnology to Develop Solutions for Coronaviruses
October 7, 2020
Exact Sciences and Pfizer Announce Extension and Amendment of their Cologuard Promotion Agreement
October 7, 2020
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions